Evidence map›Paper›PMID 34370882›Full record

ArticleClinical and experimental pharmacology & physiology2021

Azathioprine pretreatment ameliorates myocardial ischaemia reperfusion injury in diabetic rats by reducing oxidative stress, apoptosis, and inflammation.

Cuijie Lu, Ling Liu, Shuai Chen, Junfei Niu, Sheng Li, Wenxian Xie, Xiang Cheng

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental pharmacology & physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Mechanism of Action of Flavonoids ofMolecules (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cuijie LuDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Ling LiuDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Shuai ChenDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Junfei NiuDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Sheng LiDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Wenxian XieDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Xiang ChengDepartment of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
Second Affiliated Hospital of Chengdu University of Traditional Chinese · CNSichuan University of Science and Engineering · CN

Funding

Key Science and Technology Plan Project of Zigong City 2019YLSF18
6 · The paper itself

Abstract

This study was presented to observe the therapeutic effects of azathioprine (AZA) pretreatment on myocardial ischaemia reperfusion (I/R) damage in diabetic rats. All rats were randomly separated into control + sham operation; control +I/R; diabetes mellitus (DM) +I/R and DM +I/R + AZA groups. Diabetic rat models were established by intraperitoneally injecting 60 mg/kg streptozotocin (STZ). Diabetic rats were given 3 mg/kg AZA daily by gavage for 5 days. Then, myocardial I/R rat models were constructed. Myocardial infarction size and myocardial damage were respectively detected by TTC and H&E staining. Cardiac injury markers (CK-MB and MPO) and oxidative stress factors (SOD and MDA) were measured via ELISA. The protein expression of apoptotic markers (Caspase8, Caspase3, BAX and Bcl2), inflammatory factors (TLR4 and TNF-α) and AKT1/GSK3β in myocardial tissues was measured by western blot, immunohistochemistry or immunofluorescence. Data showed that AZA pretreatment could lessen myocardial infarction size and myocardial damage, and could down-regulate serum CK-MB, MPO, SOD and MDA levels in diabetic rats under I/R. Furthermore, AZA pretreatment decreased Caspase8, Caspase3, BAX, TLR4 and TNF-α expression, and increased Bcl2 expression in myocardial tissues of diabetic rats following I/R. Also, AZA pretreatment lowered AKT1, p-AKT1, GSK3β and p-GSK3β expression in diabetic heart after I/R. This study found that AZA may reduce myocardial injury in diabetic rats following I/R via reducing oxidative stress, cardiomyocyte apoptosis, and inflammatory response, which could be related to AKT1/GSK3β pathway inactivation.

Indexed as

ApoptosisAzathioprineDiabetes Mellitus, ExperimentalInflammationMyocardial Reperfusion InjuryOxidative StressRats, Sprague-DawleyAnimalsGlycogen Synthase Kinase 3 betaMaleMyocardial InfarctionProto-Oncogene Proteins c-aktRatsAzathioprineGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktapoptosisazathioprinediabetesinflammationmyocardial ischaemia reperfusionoxidative stress

Identifiers

PMID34370882
PMCPMC9291025
OpenAlexW3190589463

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.